您当前的位置:
Zeocin®
目录号 : PC26822 CAS No. : 11006-33-0
Product concentration: 100 mg/ml in solution Zeocin® is a formulation of phleomycin D1, a copper-chelated glycopeptide antibiotic produced by Streptomyces CL990. Zeocin® causes cell death by intercalating into DNA and cleaving it. The action of Zeocin® is effective on most aerobic cells. Therefore, Zeocin® is a popular and effective antibiotic for the selection of vectors bearing the Sh ble gene in a variety of cells types (bacteria, eukaryotic microorganisms, plant and animal cells). Resistance to Zeocin® is conferred by the Sh ble gene product from Streptoalloteichus hindustanus, which inactivates Zeocin® upon binding to the antibiotic . Sh ble is a small 370bp-sized gene and is carried in a number of KKL MED’s vectors. Typically, mammalian cells are sensitive to Zeocin® concentrations of 50-400 µg/ml, and bacteria to 25 µg/ml. For research use only
规格 价格 是否有货 数量
10 x 1 ml (1 g) 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

Storage and stability

- Zeocin® is shipped at room temperature. Upon receipt it should be  stored at 4°C or at -20 °C. Avoid repeated freeze-thaw cycles.

- The expiry date is specified on the product label.

- Zeocin® is sensitive to high concentrations of acids and bases but a  short-term exposure to dilute acids can be tolerated.

Note: Zeocin® is stable for 1 month at room temperature.

 

QUALITY CONTROL

Each lot is thoroughly tested to ensure the absence of lot-to-lot variation.

- Endotoxin level: < 1 EU/mg

- Physicochemical characterization (including HPLC, pH, appearance)

- Cell culture tested: potency validated in Zeocin®-sensitive and Zeocin®-resistant mammalian cell lines

- Non-cytotoxicity of trace contaminants: absence of long-term effects confirmed in Zeocin®-resistant cells

 

BACKGROUND

Zeocin® is a selective antibiotic that acts on both eukaryotic and prokaryotic cells. Resistance to Zeocin® is conferred by the Sh ble gene  from Streptoalloteichus hindustanus.

Zeocin® is the commercial name for a special formulation containing  Phleomycin, a copper-chelated glycopeptide antibiotic isolated  from a mutant strain of Streptomyces verticillus. This antibiotic of the bleomycin family exhibits activity against bacteria, eukaryotic  microorganisms, plant and animal cells. Although bleomycin antibiotics perturb plasma membranes, their activity is generally believed to be related to their ability to bind and intercalate DNA thus destroying the integrity of the double helix.

 

GENERAL GUIDELINES

Successful transfection is influenced by many factors. The health and viability of the cell line, the quality of thenucleic acid used, the transfection reagent, the duration of transfection, and the presence or absence of serum can all play a part.

 

 

SAFETY CONSIDERATIONS

Zeocin® is a harmful compound. Refer to safety data sheet for handling instructions.

 

CHEMICAL PROPERTIES

Zeocin® is a mixture of structurally related antibiotics which differ by their terminal amine residues. The antibiotics are in a copper chelated form giving the solution a blue color. Zeocin® is a labile compound which undergoes irreversible denaturation at high and low pH or in presence of a weak oxidant.

 

CONDITIONS OF SELECTION

Most cells growing aerobically are killed by 0.5 to 1000 µg/ml Zeocin®. However, the sensitivity of cells is pH dependent, i.e. the higher the pH of culture medium, the greater the sensitivity. Thus the concentration of Zeocin® required for complete growth inhibition of given cells can be reduced by increasing the pH of the medium. In addition, the activity of Zeocin® is reduced by a factor of 2 to 3 in hypertonic media, such as those used for protoplast regeneration. Hence, using low salt medium when possible decreases the amount of Zeocin® needed.

 

- Escherichia coli

The Sh ble gene and the hybrid genes in vectors provided by KKL MED are driven by synthetic E. coli promoters (i.e. EM7). The cells of the common E. coli recipient strains (i.e. HB101, DH5α, MC1061) transformed by these vectors are resistant to Zeocin®.

Note: Do not use an E. coli recipient strain that contains the Tn5 transposable element (i.e. MC1066). Tn5 encodes a bleomycin-resistance gene that will confer resistance to Zeocin®.

Zeocin-resistant transformants are selected in Low Salt LB agar medium (yeast extract 5 g/L, Tryptone 10 g/L, NaCl 5 g/L, Agar 15 g/L, pH 7.5) supplemented with 25-50 µg/ml of Zeocin®. Plates containing Zeocin® are stable for 1 month when stored at 4°C.

 

- Mammalian cells

The working concentration of Zeocin® for mammalian cell lines varies from 50 to 400 µg/ml, in a few cases can be as low as 20 µg/ml or as high as 1000 µg/ml. In a starting experiment we recommend to determine the optimal concentration of Zeocin® required to kill your host cell line. The killing and the detachment of dead cells from the plate, especially at high cell density, may require a longer time compared to G418. Foci of Zeocin-resistant stable transfectants are usually individualized after 5 days to 3 weeks incubation, depending on the cell line. Suggested concentrations of Zeocin® for selection in mammalian cells are listed on the next page.

分子式
C51H75N17O21S2
CAS号
11006-33-0
溶解性数据
Product concentration: 100 mg/ml in solution Quality Control: Each lot is thoroughly tested to ensure the absence of lot-to-lot variation. Endotoxin level: < 1 EU/mg Physicochemical characterization: HPLC, pH, appearance Cell-culture tested: potency validated in Zeocin®-sensitive and Zeocin®-resistant mammalian cell lines Non-cytotoxicity of trace contaminants: absence of long-term effects confirmed in Zeocin®-resistant cells Zeocin® is shipped at room temperature.
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2